Characteristics, Management, and Outcomes of Patients With Atrial Fibrillation Experiencing a Major Bleeding Event While on Rivaroxaban
Clinical and Applied Thrombosis/Hemostasis - United States
doi 10.1177/1076029616684030
Full Text
Open PDFAbstract
Available in full text
Date
December 21, 2016
Authors
Publisher
SAGE Publications